Gabrielle Sulzberger Cerevel Therapeutics Holdings, Inc. (CERE) insider trading activity
Gabrielle Sulzberger is of Cerevel Therapeutics Holdings, Inc.. Currently has a direct ownership of 58,876 shares of CERE, which is worth approximately $2.61 Million. The most recent transaction as insider was on Jun 05, 2024, when has been sold 10,461 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
58.9K
23.04%
3M change
23.04%
12M change
Total Value Held
$2.61 Million
Gabrielle Sulzberger Transaction History
Also insider at
GS
Gabrielle Sulzberger
Purchase, NY